Table 1.
Unweighted N | Total sample (column %) N = 4,289 | 0 Insomnia symptoms n = 3,043 | 1 Insomnia symptom n = 763 | 2 Insomnia symptoms n = 483 | p-value |
---|---|---|---|---|---|
Age, % | 0.326 | ||||
65–69 | 27.5 | 71.3 | 17.1 | 11.6 | |
70–74 | 25.2 | 73.5 | 17.5 | 9.0 | |
75–79 | 19.7 | 71.7 | 18.4 | 9.9 | |
80–84 | 15.4 | 71.8 | 16.3 | 11.9 | |
85–89 | 8.6 | 67.0 | 20.5 | 12.5 | |
90+ | 3.6 | 70.8 | 19.5 | 33 (9.7) | |
Sex, % | <0.0001 | ||||
Male | 44.3 | 75.5 | 15.8 | 8.7 | |
Female | 55.7 | 68.6 | 19.2 | 12.2 | |
Race/ethnicity, % | <0.01 | ||||
White, non-Hispanic | 84.7 | 72.3 | 17.8 | 9.9 | |
Black, non-Hispanic | 7.3 | 70.0 | 17.1 | 12.9 | |
Hispanic | 3.1 | 70.5 | 16.7 | 12.8 | |
Other† | 4.9 | 61.7 | 19.1 | 19.2 | |
Education, % | <0.0001 | ||||
<High School | 20.7 | 63.2 | 20.1 | 16.7 | |
High School Graduate | 27.0 | 68.7 | 20.7 | 10.6 | |
>High School | 52.3 | 76.5 | 15.3 | 8.2 | |
BMI (kg/m2)‡, % | 0.121 | ||||
<18.5 | 2.3 | 67.9 | 16.3 | 15.8 | |
18.5–24.9 | 32.3 | 72.4 | 16.7 | 10.9 | |
25–29.9 | 37.8 | 73.5 | 16.5 | 10.0 | |
≥30.0 | 27.6 | 743 (68.7) | 20.4 | 10.9 | |
PHQ-2§, mean ± SD | 0.96 ± 0.03 | 0.74 ± 0.03 | 1.30 ± 0.06 | 1.92 ± 0.09 | <0.0001 |
GAD-2||, mean ± SD | 0.93 ± 0.03 | 0.69 ± 0.02 | 1.35 ± 0.08 | 1.89 ± 0.08 | <0.0001 |
No. of medical conditions, % | <0.0001 | ||||
0 or 1 | 28.1 | 78.7 | 14.5 | 6.8 | |
2 | 25.1 | 75.9 | 16.3 | 7.8 | |
3 | 21.2 | 70.7 | 20.0 | 9.3 | |
4+ | 25.6 | 61.6 | 20.2 | 18.2 |
*NHATS 2011; N = 4,289; community-dwelling older adults continuously enrolled in Medicare FFS for 365 days or who died within 365 days from the interview date. Responses of “every night” or “most nights” were categorized to indicate the presence of insomnia symptoms.
†Other race/ethnicity includes American Indian, Alaska Native, Asian, Native Hawaiian, Pacific Islander, or other.
‡BMI = body mass index.
§PHQ-2 = 2-item Patient Health Questionnaire (depressive symptoms).
||GAD-2 = 2-item Generalized Anxiety Disorder Questionnaire (anxiety symptoms).